| pubmed-article:11242187 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11242187 | lifeskim:mentions | umls-concept:C0376526 | lld:lifeskim |
| pubmed-article:11242187 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11242187 | lifeskim:mentions | umls-concept:C0024305 | lld:lifeskim |
| pubmed-article:11242187 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
| pubmed-article:11242187 | lifeskim:mentions | umls-concept:C0600367 | lld:lifeskim |
| pubmed-article:11242187 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:11242187 | pubmed:dateCreated | 2001-3-12 | lld:pubmed |
| pubmed-article:11242187 | pubmed:abstractText | Human herpesvirus 8 (HHV-8) is closely associated with Kaposi's sarcoma (KS), HIV-associated Castleman's disease, and primary effusion lymphoma. As a high frequency of non-Hodgkin's lymphoma (NHL) has been reported in patients with HIV-associated KS, we hypothesized that HHV-8 infection could be indirectly implicated in the pathogenesis of NHL. We assessed the prevalence of HHV-8 antibodies in 63 patients with NHL compared with 126 HIV-infected matched control patients without NHL. Serum samples from cases and controls were assayed for antibodies to HHV-8 lytic and latent antigens using an indirect immunofluorescence assay. In patients with concordant serologic results, HHV-8 antibodies were detected in 41.5% of the NHL cases and 37% of the controls. This absence of a significant difference in HHV-8 seroprevalence between cases and controls (p =.73) does not support a possible role for HHV-8 infection in the development of NHL in HIV-infected patients. | lld:pubmed |
| pubmed-article:11242187 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11242187 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11242187 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11242187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11242187 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11242187 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:11242187 | pubmed:issn | 1525-4135 | lld:pubmed |
| pubmed-article:11242187 | pubmed:author | pubmed-author:SheldonJJ | lld:pubmed |
| pubmed-article:11242187 | pubmed:author | pubmed-author:MaillardAA | lld:pubmed |
| pubmed-article:11242187 | pubmed:author | pubmed-author:GérardLL | lld:pubmed |
| pubmed-article:11242187 | pubmed:author | pubmed-author:OksenhendlerE... | lld:pubmed |
| pubmed-article:11242187 | pubmed:author | pubmed-author:SchulzT FTF | lld:pubmed |
| pubmed-article:11242187 | pubmed:author | pubmed-author:AgbalikaFF | lld:pubmed |
| pubmed-article:11242187 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11242187 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:11242187 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:11242187 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11242187 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11242187 | pubmed:pagination | 182-4 | lld:pubmed |
| pubmed-article:11242187 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11242187 | pubmed:meshHeading | pubmed-meshheading:11242187... | lld:pubmed |
| pubmed-article:11242187 | pubmed:meshHeading | pubmed-meshheading:11242187... | lld:pubmed |
| pubmed-article:11242187 | pubmed:meshHeading | pubmed-meshheading:11242187... | lld:pubmed |
| pubmed-article:11242187 | pubmed:meshHeading | pubmed-meshheading:11242187... | lld:pubmed |
| pubmed-article:11242187 | pubmed:meshHeading | pubmed-meshheading:11242187... | lld:pubmed |
| pubmed-article:11242187 | pubmed:meshHeading | pubmed-meshheading:11242187... | lld:pubmed |
| pubmed-article:11242187 | pubmed:meshHeading | pubmed-meshheading:11242187... | lld:pubmed |
| pubmed-article:11242187 | pubmed:meshHeading | pubmed-meshheading:11242187... | lld:pubmed |
| pubmed-article:11242187 | pubmed:meshHeading | pubmed-meshheading:11242187... | lld:pubmed |
| pubmed-article:11242187 | pubmed:meshHeading | pubmed-meshheading:11242187... | lld:pubmed |
| pubmed-article:11242187 | pubmed:meshHeading | pubmed-meshheading:11242187... | lld:pubmed |
| pubmed-article:11242187 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11242187 | pubmed:articleTitle | No increased human herpesvirus 8 seroprevalence in patients with HIV-associated non-Hodgkin's lymphoma. | lld:pubmed |
| pubmed-article:11242187 | pubmed:affiliation | Department of Immunology and Hematology, Hôpital Saint-Louis, Paris, France. laurence. gerard@sls.ap-hop-paris.fr | lld:pubmed |
| pubmed-article:11242187 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11242187 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11242187 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11242187 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11242187 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11242187 | lld:pubmed |
